Please use this identifier to cite or link to this item:
http://idr.aus.ac.in/jspui/handle/21011994/319Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choudhury, Yashmin | - |
| dc.date.accessioned | 2020-03-14T07:42:13Z | - |
| dc.date.available | 2020-03-14T07:42:13Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | Cell Cycle; Vol. 14:12 | - |
| dc.identifier.issn | 1551-4005 | - |
| dc.identifier.uri | DOI: 10.1080/15384101.2015.1022066 | - |
| dc.identifier.uri | http://idr.aus.ac.in/jspui/handle/21011994/319 | - |
| dc.language.iso | en | en_US |
| dc.title | AMP-activated kinase-friend or foe in the era of targeted therapy? | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Biotechnology | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.